Peripheral nerve pathology at fixed stage in spinal muscular atrophy with respiratory distress type 1

• Published in: Brain & development (Tokyo. 1979) Vol. 40; no. 2; pp. 155 - 158
• Main Authors: Ikeda, Azusa, Yamashita, Sumimasa, Tsuyusaki, Yu, Tanaka, Mio, Tanaka, Yukichi, Hashiguchi, Akihiro, Takashima, Hiroshi, Goto, Tomohide
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-02-2018
• Subjects: Axonal degeneration; Immunoglobulin helicase µ-binding protein 2 (IGHMBP2); Neuropathological findings; Spinal muscular atrophy with respiratory distress type 1 (SMARD1); Spinal muscular atrophy with respiratory distress type 1 (SMARD1); Neuropathological findings; Immunoglobulin helicase µ-binding protein 2 (IGHMBP2); Axonal degeneration
• ISSN: 0387-7604; 1872-7131
• DOI: 10.1016/j.braindev.2017.08.004

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is characterized by severe respiratory failure due to diaphragmatic paralysis and distal muscular weakness in early infancy. After an initial decline in respiratory state and motor function until 1–2years of age, residual capabilities reach a plateau.
We report the peripheral neuropathological findings of a patient with SMARD1 at 1year and 1month of age, when his muscle strength and respiratory symptoms had deteriorated and then stabilized for several months. Peripheral nerve biopsy revealed severely progressed axonal degeneration. This finding suggests the rapid progression of peripheral axonal neuropathy in SMARD1 that leads to its characteristic clinical course of respiratory failure and paralysis in the early infantile period.